Induction of interleukin-1 and glucocorticoid hormones by HIV promotes viral replication and links human chromosome 2 to AIDS pathogenesis: Genetic mechanisms and therapeutic implications

Medical Hypotheses

Volumn 48, Issue 5, 1997, Pages 415-421

  Corley, P A ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; GLUCOCORTICOID; GLYCOPROTEIN GP 120; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CHROMOSOME 18; CHROMOSOME 2Q; HUMAN IMMUNODEFICIENCY VIRUS; KAPOSI SARCOMA; LONG TERMINAL REPEAT; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TRANSACTIVATION; VIRUS INFECTIVITY; VIRUS REPLICATION;

EID: 0030911229     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(97)90040-2     Document Type: Article

References (73)

1. Tobin E, Kandil O, Remold H G. Effect of human immunodeficiency virus on expression of HLA-DR, IL-1 beta, and TNF alpha mRNA in monocytic cells (meeting abstract). FASEB J 1990; 4: A2263.
2. Sundar S K, Cierpial M A, Kamaraju L S et al. Human immunodeficiency virus glycoprotein (gp120) infused into rat brain induces interleukin 1 to elevate pituitary-adrenal activity and decrease peripheral cellular immune responses. Proc Natl Acad Sci USA 1991; 88: 11246-11250.
3. Clouse K A, Farrar W L, Cosentino L M et al. The amino terminus of the HIV gp120 envelope protein may be necessary for stimulation of monokine secretion. Int Conf AIDS 1991; 7: 164 (abstract no. W.A. 1288).
4. Tyring S K, Cauda R, Tumbarello M et al. Synthetic peptides corresponding to sequences in HIV envelope gp41 and gp120 enhance in vitro production of interleukin-1 and tumor necrosis factor but depress production of interferon-alpha, interferon-gamma and interleukin-2. Viral Immunol 1991; 4: 33-42.
5. Corley P A. Acquired immune deficiency syndrome: the glucocorticoid solution. Med Hypotheses 1996; 47: 49-54.
6. Merrill J E, Koyanagi Y, Chen I S. Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J Virol 1989; 63: 4404-4408.
7. Kobayashi N, Hamamoto Y, Koyanagi Y, Chen I S, Yamamoto N. Effect of interleukin-1 on the augmentation of human immunodeficiency virus gene expression. Biochem Biophys Res Commun 1989; 165: 715-721.
8. Osborn L, Kunkel S, Nabel G J. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci USA 1989; 86: 2336-2340.
9. Dinarello C A. Interleukin-1. Ann NY Acad Sci 1988; 546: 122-132.
10. Klotman M E, Wong-Staal F. Human immunodeficiency virus (HIV) gene structure and genetic diversity. In: Gallo R C, Jay G, eds. The Human Retroviruses. New York: Academic Press, 1991: 35-67.
11. Starcich B R, Hahn B H, Shaw G M et al. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell 1986; 45: 637-648.
12. Weigent D A, Hoeprich P D, Bost K L et al. The HTLV-III envelope protein contains a hexapeptide homologous to a region of interleukin-2 that binds to the interleukin-2 receptor. Biochem Biophys Res Commun 1986; 139: 367-374.
13. Amadori A, Faulkner-Valle G P, De Rossi A, Zanovello P et al. HIV-mediated immunodepression: in vitro inhibition of T-lymphocyte proliferative response by ultraviolet-inactivated virus. Clin Immunol Immunopathol 1988; 46: 37-54.
14. Burkes R L, Abo W, Levine A M, Linker-Israeli M et al. Characterization of immunologic function in homosexual men with persistent, generalized lymphadenopathy and acquired immune deficiency syndrome. Cancer 1987; 59: 731-738.
15. Krasnow S W, Zhang L Q, Leung K Y et al. Tumor necrosis factor-alpha, interleukin 1, and phorbol myristate acetate are independent activators of NF-kappa B which differentially activate T cells. Cytokine 1991; 3: 372-379.
16. Wong K K, Lu D, Podsakoff G, Brar D, Chatterjee S. Efficient gene transfer to primary human CD4+ T lymphocytes, monocyte-macrophages, and CD34+ hematopoietic stem cells mediated by adeno-associated virus-based vectors: prospects for the gene therapy of AIDS. Natl Conf Hum Retroviruses Relat Infect (2nd) 1995: 142.
17. Pruss D, Reeves R, Bushman F D, Wolffe A P. The influence of DNA and nucleosome structure on integration events directed by HIV integrase. J Biol Chem 1994; 269: 25031-25041.
18. Muller H P, Varmus H E. DNA bending creates favored sites for retroviral integration: an explanation for preferred insertion sites in nucleosomes. EMBO J 1994; 13: 4704-4714.
19. Pruss D, Bushman F D, Wolffe A P. Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core. Proc Natl Acad Sci USA 1994; 91: 5913-5917.
20. Newstein M, Stanbridge E J, Casey G, Shank P R. Human chromosome 12 encodes a species-specific factor which increases human immunodeficiency virus type 1 tat-mediated trans activation in rodent cells. J Virol 1990; 64: 4565-4567.
21. Cupelli L A. Roles of retroviral R regions in long terminal repeat-driven gene expression. Diss Abstr Int [B] 1992; 53: 1708.
22. Rasheed S, Kaplan B, Shieh C K, Li Z. High expression of c-myc gene is associated with chromosomal translocation in AIDS-related B-cell lymphoma. Int Conf AIDS 1992; 8: A16 (abstract no. PoA 2078).
23. Corley P A. HIV and the cortisol connection: a feasible concept of the process of AIDS. Med Hypotheses 1995; 44: 483-489.
24. Nicklin M J, Weith A, Duff G W. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics 1994; 19: 382-384.
25. Steinkasserer A, Spurr N K, Cox S, Jeggo P, Sim R B. The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci. Genomics 1992; 13: 654-657.
26. Ohara N, Hayashi K, Miyamoto K et al. A human T cell line with an abnormal trisomy 2 karyotype established by coculture of peripheral lymphocytes with an HTLV-II-infected simian leukocyte cell line. Acta Pathol Jpn 1993; 43: 237-243.
27. Kaelbling M, Eddy R, Shows TB et al. Localization of the human gene allowing infection by gibbon ape leukemia virus to human chromosome region 2q11-q14 and to the homologous region on mouse chromosome 2. J Virol 1991; 65: 1743-1747.
28. Berkowicz M, Rozner E, Rechavi G et al. Translocation t(2; 8) in AIDS-associated Burkitt leukemia [letter]. Cancer Genet Cytogenet 1989; 38: 131.
29. Yoshizawa K, Kiyosawa K, Yamada S et al. Establishment of Epstein-Barr virus-associated lymphoma cell line SUBL with t(2;3) (p11;q27) from a liver transplant patient. Cancer Genet Cytogenet 1993; 71: 155-163.
30. Schlegelberger B, Grote W, Wacker H H, Bartels H. t(2;3) (p12;q27) in Hodgkin's disease of a human immunodeficiency virus-positive patient with hemophilia [letter; comment]. Blood 1993; 81: 265-267.
31. Shabtai F, Klar D, Kimchi D et al. Juxta-centromeric fragility of chromosomes 1, 2, 9, 16, and immunodeficiency. Special reference to the fragility of chromosome 2 and its oncogenic potential. Anticancer Res 1984; 4: 235-239.
32. Taruscio D, Manuelidis L. Chromosomal integration sites of endogenous retroviral sequences. Int Conf AIDS 1991; 7: 132 (abstract no. M.A. 1163).
33. Steinkasserer A, Spurr N K, Sim R B. Chromosomal mapping of the human interleukin-1 receptor antagonist gene (IL-1RN) and isolation of specific YAC clones. Agents Actions 1993; 38 Spec No: C59-C60.
34. Patterson D, Jones C, Hart I et al. The human interleukin-1 receptor antagonist (IL1RN) gene is located in the chromosome 2q14 region. Genomics 1993; 15: 173-176.
35. Merrill J E, Koyanagi Y, Chen I S. Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J Virol 1989; 63: 4404-4408.
36. Kinter A L, Poli G, Weissman D, Fauci A S. Interleukin-1 (IL-1) induction of HIV expression in chronically infected promonocytic U1 cells is independent of the activation of NFkB and is blocked by the IL-1 receptor antagonist (IL-1RA). Int Conf AIDS 1993; 9: 173 (abstract no. PO-A13-0230).
37. Sadeghi H M, Weiss L, Kazatchkine M D, Haeffner-Cavaillon N. Antiretroviral therapy suppresses the constitutive production of interleukin-1 associated with human immunodeficiency virus infection. J Infect Dis 1995; 172: 547-550.
38. Zavala F, Rimaniol A C, Boussin F et al. HIV predominantly induces IL-1 receptor antagonist over IL-1 synthesis in human primary monocytes. J Immunol 1995; 155: 2784-2793.
39. Hovanessian A G, Marie I, Blank U et al. The role of CD26 in HIV infection: viral entry and its cytopathic effect. Int Conf AIDS 1994; 10: 89 (abstract no. 307A).
40. Abbott C A, Baker E, Sutherland G R, McCaughan G W. Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene. Immunogenetics 1994; 40: 331-338.
41. Fujiwara H, Fukuoka M, Yasuda K et al. Cytokines stimulate dipeptidyl peptidase-IV expression on human luteinizing granulosa cells. J Clin Endocrinol Metab 1994; 79: 1007-1011.
42. Reinhold D, Bank U, Buhling F et al. Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells, and IL-2 and IL-6 production. Immunobiology 1993; 188: 403-414.
43. Zhou A, Bloomquist B T, Mains R E. The prohormone convertases PC1 and PC2 mediate distinct endoproteolytic cleavages in a strict temporal order during proopiomelanocortin biosynthetic processing. J Biol Chem 1993; 268: 1763-1769.
44. Chowdhary B P, Gustavsson I, Wikberg J E, Chhajlani V. Localization of the human melanocortin-5 receptor gene (MC5R) to chromosome band 18p11.2 by fluorescence in situ hybridization. Cytogenet Cell Genet 1995; 68: 79-81.
45. Capra E, Rindi G, Santi G, Spina M P, Scappaticci S. Chromosome abnormalities in a case of pituitary adenoma. Cancer Genet Cytogenet 1993; 68: 140-142.
46. Leib-Mosch C, Barton D E, Brack-Werner R et al. Genetic characterization of a human endogenous retroviral element located on chromosome 18q21. Hamatol Bluttransfus 1989; 32: 461-463.
47. Brack-Werner R, Barton D E, Werner T et al. Human SSAV-related endogenous retroviral element: LTR-like sequence and chromosomal localization to 18q21. Genomics 1989; 4: 68-75.
48. Shibata D, Hu E, Weiss L M, Brynes R K, Nathwani B N. Detection of specific t(14;18) chromosomal translocations in fixed tissues. Hum Pathol 1990; 21: 199-203.
49. Bilgrami S, Shafi N, Pesanti E L et al. Mantle-cell lymphoma in a patient with human immunodeficiency viral infection. ACTA Haematol 1995; 93: 101-104.
50. Verani D A. Association of non-Hodgkin's lymphoma and Kaposi's sarcoma in a patient with HIV infection: case report. Boll Ist Sieroter Milan 1991-1992; 70: 453-455.
51. Picchio G R, Cohen J I, Wyatt E R, Mosier D E. Enhanced tumorigenicity of an Epstein-Barr virus-transformed lymphoblastoid cell line is associated with a unique 1:18 chromosomal translocation and decreased expression of lymphocyte function associated antigen-1a (CD11A). Am J Pathol 1993; 143: 342-349.
52. Dominy S S. Is peptide T, an octapeptide sequence found in the external glycoprotein coat of the human immunodeficiency virus (HIV), a fragment of a retro-copy of the gamma-3-MSH neuropeptide? Med Hypotheses 1988; 27: 1-4.
53. Picard C, Matherson S, Salmon D et al. Hyperpigmented erythrodermias in AIDS. Int Conf AIDS 1990; 6: 219 (abstract no. Th.B.390).
54. Milpied B, Dutartre H, Huard A et al. Skin hyperpigmentation in AIDS patients = an hypophyse dysfunction? Int Conf AIDS 1991; 7: 230 (abstract no. M.B.2193).
55. Cesarman E, Moore P S, Rao P H et al. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 1995; 86: 2708-2714.
56. Kasckow J W, Mulcahey J J, Han J H et al. Interleukin-1 alpha induces corticotropin-releasing factor secretion and synthesis from NPLC-KC cells through various second messenger pathways. Synapse 1994; 18: 354-358.
57. Sandi C, Guaza C. Evidence for a role of nitric oxide in the corticotropin-releasing factor release induced by interleukin-1 beta. Eur J Pharmacology 1995; 274: 17-23.
58. Guo W, Antakly T, Cadotte M et al. Increased levels of glucocorticoid receptor (GR) expression in AIDS-Kaposi's sarcoma (KS) (Meeting abstract). Proc Annu Meet Am Assoc Cancer Res 1993; 34: A3016.
59. Cooper J S, Steinfeld A D, Lerch I A. The prognostic significance of residual pigmentation following radiotherapy of epidemic Kaposi's sarcoma. J Clin Oncol 1989; 7: 619-621.
60. Uehara Y, Shimizu H, Sato N, Mura Y S, Mori M. The dipeptide Lys-Pro attenuates interleukin-1 beta-induced anorexia. Peptides 1993: 14: 175-178.
61. Davidson J, Milton A S, Rotondo D. Alpha-melanocyte-stimulating hormone suppresses fever and increases in plasma levels of prostaglandin E2 in the rabbit. J Physiol (Lond) 1992; 451: 491-502.
62. Kim K, Huang Y, Li J et al. HIV-1 infection and modulation of cytokine and growth factor expression in AIDS-Kaposi's sarcoma derived cells. Int Conf AIDS 1992; 8: Th74 (abstract no. ThD 1547).
63. Albini A, Barillari G, Benelli R, Gallo R C, Ensoli B. Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci USA 1995; 92: 4838-4842.
64. Ensoli B, Nakamura S, Salahuddin S Z et al. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 1989; 243: 223-226.
65. Louie S, Cai J, Law R et al. Effects of interleukin-1 and interleukin-1 receptor antagonist in AIDS-Kaposi's sarcoma. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 455-460.
66. Yang J, Offermann M K. Interleukin-6 is synergistically induced in Kaposi's sarcoma cells by interleukin-1 beta and double-stranded RNA (Meeting abstract). Proc Annu Meet Am Assoc Cancer Res 1993; 34; A2628.
67. Huang Y Q, Li J J, Kim K S et al. HIV-1 infection and modulation of cytokine and growth factor expression in Kaposi's sarcoma-derived cells in vitro. AIDS 1993: 7: 317-322.
68. Besedovsky H, del Rey A, Sorkin E, Dinarello C A. Immuno-regulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986; 233: 652-654.
69. Justement J S, Poli G, Fauci A S. Glucocorticoids act synergistically with recombinant cytokines to induce HIV expression in chronically infected promonocyte cells. Int Conf AIDS 1990; 6: 162 (abstract no. S.A.322).
70. Mugridge K G, Perretti M, Ghiara P, Parente L. Alpha-melanocyte-stimulating hormone reduces interleukin-1 beta effects on rat stomach preparations possibly through interference with a type I receptor. Eur J Pharmacol 1991; 197: 151-155.
71. Catania A, Airaghi L, Manfredi MG et al. Proopiomelano-cortin-derived peptides and cytokines: relations in patients with acquired immunodeficiency syndrome. Clin Immunol Immunopathol 1993; 66: 73-79.
72. Brooks E H. Eumelanin pigmentation is a host-specific factor influencing immune response and HIV progression. Int Conf AIDS 1992; 8: 15 (abstract no. PuA 6026).
73. Catania A, Lipton J M. Alpha-melanocyte-stimulating hormone peptides in host responses: from basic evidence to human research. Ann NY Acad Sci 1993; 680: 412-423.